Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 336

1.

Ret protein expression in adrenal medullary hyperplasia and pheochromocytoma.

Powers JF, Brachold JM, Tischler AS.

Endocr Pathol. 2003 Winter;14(4):351-61.

PMID:
14739491
2.

The RET proto-oncogene in sporadic pheochromocytomas.

Takaya K, Yoshimasa T, Arai H, Tamura N, Miyamoto Y, Itoh H, Nakao K.

Intern Med. 1996 Jun;35(6):449-52.

3.

Adrenergic differentiation and Ret expression in rat pheochromocytomas.

Powers JF, Picard KL, Nyska A, Tischler AS.

Endocr Pathol. 2008 Spring;19(1):9-16. doi: 10.1007/s12022-008-9019-1.

PMID:
18317952
4.

[Pheochromocytoma--pathohistologic and immunohistochemical aspects].

Tatić S, Havelka M, Paunović I, Bozić V, Diklic A, Brasanac D, Janković R, Jancić-Zguricas M.

Srp Arh Celok Lek. 2002 Jul;130 Suppl 2:7-13. Serbian.

PMID:
12584991
5.

Up-regulation of ret by reserpine in the adult rat adrenal medulla.

Powers JF, Brachold JM, Ehsani SA, Tischler AS.

Neuroscience. 2005;132(3):605-12. Erratum in: Neuroscience. 2006;137(1):365-6.

PMID:
15837122
6.

Expression of the RET proto-oncogene in normal human tissues, pheochromocytomas, and other tumors of neural crest origin.

Takaya K, Yoshimasa T, Arai H, Tamura N, Miyamoto Y, Itoh H, Nakao K.

J Mol Med (Berl). 1996 Oct;74(10):617-21.

PMID:
8912182
7.

Adrenal ganglioneuromas in children with multiple endocrine neoplasia type 2: a report of two cases.

Lora MS, Waguespack SG, Moley JF, Walvoord EC.

J Clin Endocrinol Metab. 2005 Jul;90(7):4383-7. Epub 2005 Apr 12.

PMID:
15827098
8.

Expression of the ret proto-oncogene in human medullary thyroid carcinomas and pheochromocytomas of MEN 2A.

Miya A, Yamamoto M, Morimoto H, Tanaka N, Shin E, Karakawa K, Toyoshima K, Ishizaka Y, Mori T, Takai S.

Henry Ford Hosp Med J. 1992;40(3-4):215-9.

PMID:
1362408
9.

Pheochromocytomas in Nf1 knockout mice express a neural progenitor gene expression profile.

Powers JF, Evinger MJ, Zhi J, Picard KL, Tischler AS.

Neuroscience. 2007 Jul 29;147(4):928-37. Epub 2007 Jun 20.

PMID:
17582688
10.

Detection of ret homodimers in MEN 2A-associated pheochromocytomas.

Wada M, Asai N, Tsuzuki T, Maruyama S, Ohiwa M, Imai T, Funahashi H, Takagi H, Takahashi M.

Biochem Biophys Res Commun. 1996 Jan 17;218(2):606-9.

PMID:
8561803
11.

A newly detected mutation of the RET protooncogene in exon 8 as a cause of multiple endocrine neoplasia type 2A.

Bethanis S, Koutsodontis G, Palouka T, Avgoustis C, Yannoukakos D, Bei T, Papadopoulos S, Linos D, Tsagarakis S.

Hormones (Athens). 2007 Apr-Jun;6(2):152-6.

12.

Multiple endocrine neoplasia type 2.

Gertner ME, Kebebew E.

Curr Treat Options Oncol. 2004 Aug;5(4):315-25. Review.

PMID:
15233908
13.

A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells.

Califano D, D'Alessio A, Colucci-D'Amato GL, De Vita G, Monaco C, Santelli G, Di Fiore PP, Vecchio G, Fusco A, Santoro M, de Franciscis V.

Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7933-7.

14.

Multiple endocrine neoplasia type 2 and the RET protooncogene: from bedside to bench to bedside.

Machens A, Dralle H.

Mol Cell Endocrinol. 2006 Mar 9;247(1-2):34-40. Epub 2005 Dec 15. Review.

PMID:
16343738
15.

Ganglioneuromas and renal anomalies are induced by activated RET(MEN2B) in transgenic mice.

Sweetser DA, Froelick GJ, Matsumoto AM, Kafer KE, Marck B, Palmiter RD, Kapur RP.

Oncogene. 1999 Jan 28;18(4):877-86.

16.

RET expression and neuron-like differentiation of pheochromocytoma and normal chromaffin cells.

Powers JF, Picard KL, Tischler AS.

Horm Metab Res. 2009 Sep;41(9):710-4. doi: 10.1055/s-0029-1224136. Epub 2009 Jun 23.

PMID:
19551609
17.

Pheochromocytoma in multiple endocrine neoplasia type II: an example of the two-hit theory of neoplasia.

Cerny JC, Jackson CE, Talpos GB, Yott JB, Lee MW.

Surgery. 1982 Nov;92(5):849-52.

PMID:
6127813
18.

C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B.

Smith-Hicks CL, Sizer KC, Powers JF, Tischler AS, Costantini F.

EMBO J. 2000 Feb 15;19(4):612-22.

19.

Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.

Dannenberg H, Komminoth P, Dinjens WN, Speel EJ, de Krijger RR.

Endocr Pathol. 2003 Winter;14(4):329-50. Review.

PMID:
14739490
20.

[Genetics of endocrine tumours].

Calender A, Dupasquier S, Cordier M, Zhang CX; Groupe d'Etude des Tumeurs Endocrines.

Ann Pathol. 2005 Dec;25(6):463-86. Review. French.

PMID:
16735973
Items per page

Supplemental Content

Write to the Help Desk